Back to top

Edwards Lifesciences Advances Real-World Study on New Aortic Valve Conduit

Edwards Lifesciences Corp. ($EW) announced an update on their ongoing clinical study. The KONECTION study, officially titled “KONECT RESILIA Aortic...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Edwards Lifesciences Corporation (EW)